Navigating the landscape of core outcome set development in dermatology - 21/06/19

Doi : 10.1016/j.jaad.2019.03.009

Cecilia A.C. Prinsen, PhD ^a, Phyllis I. Spuls, MD, PhD ^b, Jan Kottner, PhD ^c,^d,^⁎ , Kim S. Thomas, PhD ^e, Christian Apfelbacher, PhD ^f, Joanne R. Chalmers, PhD ^e, Stefanie Deckert, MPH ^g, Masutaka Furue, PhD ^h, Louise Gerbens, PhD ^b, Jamie Kirkham, PhD ⁱ, Eric L. Simpson, PhD ^j, Murad Alam, MD ^k, Katrin Balzer, PhD ^l, Dimitri Beeckman, PhD ^d, Viktoria Eleftheriadou, PhD ^e, Khaled Ezzedine, MD ^m, Sophie E.R. Horbach, PhD ⁿ, John R. Ingram, MD, PhD ^o, Alison M. Layton, MD ^p,^q, Karsten Weller, PhD ^c, Thomas Wild, MD ^r,^s,^t, Albert Wolkerstorfer, PhD ^b, Hywel C. Williams, DSc ^e, Jochen Schmitt, MD, MPH ^g
^a Amsterdam UMC, Department of Epidemiology and Biostatistics, Vrije Universiteit University Medical Center, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands
^b Amsterdam UMC, Department of Dermatology, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands
^c Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany
^d University Centre for Nursing and Midwifery, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
^e Centre of Evidence-Based Dermatology, University of Nottingham, Nottingham, United Kingdom
^f Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany
^g Center for Evidence-Based Healthcare, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
^h Department of Dermatology, Kyushu University, Fukuoka, Japan
ⁱ Medical Research Council North West Hub for Trials Methodology Research, Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom
^j Department of Dermatology, Oregon Health & Science University, Portland, Oregon
^k Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
^l Institute for Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany
^m Department of Dermatology and Evaluation of Therapeutics, EA7379, Paris-Est University, University Paris Est Créteil, University Hospital Departments Viruses, Immunity, and Cancer, Créteil, France
ⁿ Amsterdam UMC, Department of Plastic, Reconstructive, and Hand Surgery, University of Amsterdam, Amsterdam, the Netherlands
^o Division of Infection and Immunity, University Hospital of Wales, Cardiff University, Cardiff, United Kingdom
^p Hull York Medical School, University of York, York, United Kingdom
^q Harrogate and District National Health Service Foundation Trust, Harrogate, United Kingdom
^r Department of Plastic, Aesthetic, and Hand Surgery, Interdisciplinary Center for Treatment of Chronic Wounds, Dessau Medical Center, Dessau, Germany
^s Department of Dermatology, Venereology, Allergology, and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany
^t Institut of Applied Bio-Sciences and Process Management, University of Applied Science Anhalt, Koethen, Germany

^∗Reprint requests: Jan Kottner, PhD, Charité-Universitätsmedizin Berlin, Department of Dermatology and Allergy, Charitéplatz 1, 10117 Berlin, Germany.Charité-Universitätsmedizin BerlinDepartment of Dermatology and AllergyCharitéplatz 1Berlin10117Germany

Abstract

The development of core outcome sets (COSs; ie, a minimum set of core outcomes that should be measured and reported in all trials or in clinical practice for a specific condition) in dermatology is increasing in pace. A total of 44 dermatology-related COS projects have been registered in the online Core Outcome Measures in Effectiveness Trials database (search) and include studies on 26 different skin diseases. With the increasing number of COSs in dermatology, care is needed to ensure the delivery of high-quality COSs that meet quality standards when using state-of-the-art methods. In 2015, the Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) was established. CS-COUSIN is an international, multidisciplinary working group aiming to improve the development and implementation of COSs in dermatology. CS-COUSIN has developed guidance on how to develop high-quality COSs for skin diseases and supports dermatology-specific COS initiatives. Currently, 17 COS development groups are affiliated with CS-COUSIN and following standardized COS development processes. To ensure successful uptake of COSs in dermatology, researchers, clinicians, systematic reviewers, guideline developers, and other stakeholders should use existing COSs in their work.

Le texte complet de cet article est disponible en PDF.

Key words : clinical trials, Cochrane Skin, core outcome set, CS-COUSIN, dermatology, development, implementation

Abbreviations used : COMET, COS, COSMIN, CS-COUSIN, HOME, OMERACT

Plan

Early pioneers of outcome standardization in medicine

Developing standards for COS development

Core outcome set development in dermatology

The challenge to uptake of COSs

	Funding sources: None.
	Conflicts of interest: All authors are members of the Cochrane Skin–Core Outcome Set Initiative.

Export

Vol 81 - N° 1

P. 297-305 - juillet 2019 Retour au numéro

Article précédent

Future considerations for clinical dermatology in the setting of 21st century American policy reform: Corporatization and the rise of private equity in dermatology
Sailesh Konda, Joseph Francis, Kiran Motaparthi, Jane M. Grant-Kels, Group for Research of Corporatization and Private Equity in Dermatology

| Article suivant

Beyond JAAD July 2019: Articles of interest to dermatologists from the nondermatologic literature
Andrew Bronin, Robert Phelps, Robert Sidbury

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Navigating the landscape of core outcome set development in dermatology - 21/06/19

Abstract

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL